These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

874 related items for PubMed ID: 21685829

  • 1. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A.
    Transplantation; 2011 Jul 27; 92(2):217-23. PubMed ID: 21685829
    [Abstract] [Full Text] [Related]

  • 2. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ, Zaas AK, Hanson KE, Palmer SM.
    J Heart Lung Transplant; 2007 Dec 27; 26(12):1286-92. PubMed ID: 18096480
    [Abstract] [Full Text] [Related]

  • 3. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E, Ozaki KS, Tomiyama H, Granato CF, Camara NO, Pacheco-Silva A.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):2031-7. PubMed ID: 17161359
    [Abstract] [Full Text] [Related]

  • 4. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V, Bravo S, Van Renterghem L, de Moerloose B, Benoit Y, Laureys G, Dhooge C.
    Transpl Infect Dis; 2008 Feb 20; 10(1):19-23. PubMed ID: 17511814
    [Abstract] [Full Text] [Related]

  • 5. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
    West P, Schmiedeskamp M, Neeley H, Oberholzer J, Benedetti E, Kaplan B.
    Transpl Infect Dis; 2008 Apr 20; 10(2):129-32. PubMed ID: 17605740
    [Abstract] [Full Text] [Related]

  • 6. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K, Kanda Y, Kako S, Asano-Mori Y, Watanabe T, Motokura T, Chiba S, Shiraki K, Kurokawa M.
    J Med Virol; 2008 Oct 20; 80(10):1769-75. PubMed ID: 18712833
    [Abstract] [Full Text] [Related]

  • 7. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M, Burroughs AK, Sweny P, Hassan-Walker AF, Okwuadi S, Sabin C, Amooty G, Brown VS, Grace SC, Emery VC, Griffiths PD.
    J Infect Dis; 2004 Apr 15; 189(8):1355-61. PubMed ID: 15073671
    [Abstract] [Full Text] [Related]

  • 8. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
    Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M.
    Lancet; 2000 Aug 19; 356(9230):645-9. PubMed ID: 10968438
    [Abstract] [Full Text] [Related]

  • 9. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan.
    Yang SL, Lin TW, Lin HC, Wang HY, Chang PY, Wang PN, Yang S, Lu JJ.
    J Microbiol Immunol Infect; 2021 Oct 19; 54(5):971-978. PubMed ID: 33632621
    [Abstract] [Full Text] [Related]

  • 10. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
    Peixoto M, Mascarenhas L, Cunha A, Dutra M, Miranda E, Silva I, Costa S, Galvão B, Cunha A.
    Antivir Ther; 2012 Oct 19; 17(3):585-8. PubMed ID: 22293247
    [Abstract] [Full Text] [Related]

  • 11. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J, Caston-Osorio JJ, Martín C, Rivero A, Doblas A, Rojas R, Gómez P, Martínez F, Torres A.
    Enferm Infecc Microbiol Clin; 2010 Jan 19; 28(1):6-12. PubMed ID: 19409666
    [Abstract] [Full Text] [Related]

  • 12. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J, Rotjanapan P, Watcharananan SP.
    Transplant Proc; 2017 Jun 19; 49(5):1048-1052. PubMed ID: 28583524
    [Abstract] [Full Text] [Related]

  • 13. Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens.
    Minces LR, Nguyen MH, Mitsani D, Shields RK, Kwak EJ, Silveira FP, Abdel-Massih R, Pilewski JM, Crespo MM, Bermudez C, Bhama JK, Toyoda Y, Clancy CJ.
    Antimicrob Agents Chemother; 2014 Jun 19; 58(1):128-35. PubMed ID: 24145525
    [Abstract] [Full Text] [Related]

  • 14. Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene.
    Leung PYM, Tran T, Testro A, Paizis K, Kwong J, Whitlam JB.
    Transpl Infect Dis; 2019 Dec 19; 21(6):e13168. PubMed ID: 31498954
    [Abstract] [Full Text] [Related]

  • 15. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM, Scott GM, Naing Z, Glanville AR, Rawlinson WD.
    Transpl Infect Dis; 2011 Apr 19; 13(2):145-53. PubMed ID: 21070537
    [Abstract] [Full Text] [Related]

  • 16. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E, Suter F, Baruzzo S, Perani V, Moioli F, Remuzzi G.
    Clin Transplant; 1996 Dec 19; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D, Ogawa Y, Fujita H, Morita K, Sasaki H, Oishi Y, Higuchi H, Hatanaka K, Shinohara N.
    Nephrology (Carlton); 2016 Jul 19; 21 Suppl 1():63-6. PubMed ID: 26970406
    [Abstract] [Full Text] [Related]

  • 18. Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.
    Cintra-Cabrera M, Suárez-Benjumea A, Bernal-Blanco G, González-Roncero FM, Toapanta-Gaibor NG, Súñer-Poblet M, Pérez-Valdivia MÁ, Fernández-Cuenca F, Gentil-Govantes MÁ, Rocha-Castilla JL.
    Transplant Proc; 2018 Mar 19; 50(2):575-577. PubMed ID: 29579856
    [Abstract] [Full Text] [Related]

  • 19. Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.
    Gilbert C, LeBlanc MH, Boivin G.
    Herpes; 2001 Nov 19; 8(3):80-2. PubMed ID: 11867025
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
    Sánchez Puch S, Ochoa C, Carballal G, Zala C, Cahn P, Brunet R, Salomón H, Videla C.
    J Clin Virol; 2004 Jul 19; 30(3):271-5. PubMed ID: 15135748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.